$4.230
+0.010 (+0.24%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
ABUS Prediction & Forecast by Similar Chart Analysis
Alphio's ABUS stock price prediction model matches the current Arbutus Biopharma Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.22 (-0.27%). The 1-week path is $4.22 (-0.16%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Arbutus Biopharma Corp Stock?
Currently, ABUS is not a strong buy due to its recent performance and technical indicators. The stock is trading at $4.22, which is below the analyst price target of $5.14, suggesting some upside potential. However, the RSI is at 38.6, indicating that the stock is nearing oversold conditions, but not yet in a strong buy zone. Additionally, the stock has experienced a 20-day change of -15.77%, reflecting recent downward pressure.
ABUS stock price ended at $4.23 on Monday, after rising +0.24%
Arbutus Biopharma Corp (ABUS) last closed at $4.23, gaining +0.24%. These facts feed the 1-day and 1-week ABUS price prediction above.
Analyst Consensus
Arbutus Biopharma Corp (ABUS): 6 buy, 1 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Arbutus Biopharma Corp (ABUS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches ABUS, ranked by similarity.
Seasonality analysis for ABUS
Historically the probability of a positive October return for ABUS is 77.97%. November offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for ABUS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $2.37 | $2.65 | $2.92 | -37.25% |
| Nov 2026 | $2.25 | $2.55 | $2.93 | -39.68% |
| Dec 2026 | $2.71 | $2.82 | $3.18 | -33.32% |
In 2026, Arbutus Biopharma Corp (ABUS) is projected to range from $2.25 to $3.18.
Arbutus Biopharma Corp 2026 monthly forecast
In Oct 2026, Arbutus Biopharma Corp is projected to average $2.65, with a low of $2.37 and high of $2.92.
In Nov 2026, Arbutus Biopharma Corp is projected to average $2.55, with a low of $2.25 and high of $2.93.
In Dec 2026, Arbutus Biopharma Corp is projected to average $2.82, with a low of $2.71 and high of $3.18.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.